OMER RSI Chart
Last 7 days
-2.0%
Last 30 days
3.0%
Last 90 days
-29.6%
Trailing 12 Months
-40.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 15.2M | 0 | 0 | 0 |
2023 | 7.4M | 0 | 11.3M | 13.8M |
2022 | 2.5M | 0 | 3.3M | 4.1M |
2021 | 71.3M | 86.6M | 44.2M | 1.7M |
2020 | 113.6M | 100.3M | 96.6M | 73.8M |
2019 | 50.1M | 75.2M | 100.4M | 111.8M |
2018 | 56.1M | 47.3M | 38.6M | 29.9M |
2017 | 46.5M | 53.6M | 64.0M | 64.8M |
2016 | 20.4M | 27.2M | 35.2M | 41.4M |
2015 | 827.0K | 4.0M | 7.0M | 13.5M |
2014 | 605.0K | 510.0K | 528.0K | 539.0K |
2013 | 5.6M | 4.2M | 3.0M | 1.6M |
2012 | 4.8M | 5.2M | 5.6M | 6.0M |
2011 | 3.0M | 3.6M | 4.4M | 4.5M |
2010 | 0 | 1.7M | 1.9M | 2.1M |
2009 | 0 | 0 | 0 | 1.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 17, 2023 | demopulos gregory a md | bought | 25,200 | 1.68 | 15,000 | chairman, ceo & president |
Nov 15, 2023 | demopulos peter a md | bought | 15,300 | 1.53 | 10,000 | - |
Nov 14, 2023 | demopulos gregory a md | acquired | 36,000 | 1.44 | 25,000 | chairman, ceo & president |
Nov 13, 2023 | demopulos gregory a md | acquired | 48,375 | 1.29 | 37,500 | chairman, ceo & president |
Sep 12, 2023 | bumol thomas f. | acquired | 33,100 | 3.31 | 10,000 | - |
May 22, 2023 | hanish arnold c | sold | -32,300 | 6.46 | -5,000 | - |
May 22, 2023 | hanish arnold c | acquired | 26,500 | 5.3 | 5,000 | - |
May 22, 2023 | cable thomas j. | sold | -32,650 | 6.53 | -5,000 | - |
May 22, 2023 | cable thomas j. | acquired | 26,500 | 5.3 | 5,000 | - |
Sep 08, 2021 | hanish arnold c | acquired | 94,400 | 9.44 | 10,000 | - |
Which funds bought or sold OMER recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | B. Riley Wealth Advisors, Inc. | added | 6.95 | -2,113 | 44,910 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -80.28 | -170,850 | 44,888 | -% |
May 16, 2024 | COMERICA BANK | added | 20.00 | 21,750 | 103,500 | -% |
May 16, 2024 | Ancora Advisors LLC | reduced | -27.29 | -124,143 | 408,942 | 0.01% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.91 | -11,648 | 21,117 | -% |
May 15, 2024 | Squarepoint Ops LLC | sold off | -100 | -122,664 | - | -% |
May 15, 2024 | TOWNSQUARE CAPITAL LLC | new | - | 67,248 | 67,248 | -% |
May 15, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 6.83 | 14,000 | 122,000 | -% |
May 15, 2024 | Saltoro Capital, LP | sold off | -100 | -600,000 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -35.38 | -177,135 | 379,456 | -% |
Unveiling Omeros Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Omeros Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Omeros Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -0.4% | 3,415,000 | 3,429,000 | 4,413,000 | 3,963,000 | 1,993,000 | 906,000 | 493,000 | 9,936,333 | 19,379,667 | 28,823,000 | 21,061,000 | 10,632,000 | 26,114,000 | 13,530,000 | 23,537,000 | 33,417,000 | 29,856,000 | 26,753,000 | 21,779,000 | 22,017,000 | 4,608,000 |
Costs and Expenses | -1.8% | 39,034,000 | 39,765,000 | 48,153,000 | 35,713,000 | 40,138,500 | 50,766,000 | 35,046,000 | 42,889,000 | 39,828,000 | 45,610,000 | 45,290,000 | 44,448,000 | 51,542,000 | 41,210,000 | 47,214,000 | 57,121,000 | 40,957,000 | 36,091,000 | 41,018,000 | 40,491,000 | 40,050,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 41,018,000 | 40,491,000 | 40,050,000 |
S&GA Expenses | 12.8% | 12,264,000 | 10,875,000 | 16,422,000 | 11,103,000 | 13,589,000 | 12,198,000 | 10,959,000 | 12,562,000 | 14,010,000 | 15,484,000 | 12,786,000 | -5,486,000 | 19,825,000 | 16,931,000 | 18,036,000 | -8,779,000 | 16,933,000 | 16,928,000 | 14,632,000 | 14,888,000 | 13,152,000 |
R&D Expenses | -7.3% | 26,770,000 | 28,890,000 | 31,731,000 | 24,610,000 | 26,549,500 | 38,568,000 | 24,087,000 | 30,327,000 | 25,818,000 | 30,126,000 | 32,504,000 | 23,253,000 | 31,316,000 | 24,132,000 | 28,911,000 | 37,215,500 | 23,746,000 | 19,108,000 | 26,255,000 | 25,446,000 | 26,862,000 |
EBITDA Margin | 9.5% | -9.85 | -10.89 | -13.26 | -21.14 | -38.99 | -73.32 | -95.83 | -138 | -5.53 | -2.73 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | 16.5% | 8,231,000 | 7,063,000 | 7,916,000 | 7,933,000 | 7,902,500 | 4,932,000 | 4,941,000 | 4,951,000 | 4,911,000 | 4,910,000 | 4,897,000 | 7,988,000 | 6,882,000 | 5,978,000 | 5,903,000 | 5,811,500 | 5,715,000 | 5,530,000 | 5,600,000 | 5,148,500 | 4,602,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | -15,402,000 | -7,854,000 | - | - | - | - | - | - | - | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | -105,160,000 | -22,703,000 | - | - | -87,747,000 | -46,317,000 | - | - | -111,881,000 | -16,463,000 | - | - | - | - |
EBT Margin | 9.3% | -11.96 | -13.19 | -16.14 | -24.75 | -44.81 | -79.66 | -104 | -150 | -6.08 | -3.03 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -310.1% | -37,184,000 | -9,068,000 | -37,750,000 | -33,701,000 | 128,733,000 | -17,456,000 | -33,011,000 | 280,621,000 | -22,703,000 | -28,593,000 | -35,090,000 | -37,273,000 | -38,463,000 | -33,294,000 | -29,031,000 | -29,225,000 | -16,463,000 | -14,453,000 | -24,345,000 | -23,534,000 | -39,472,000 |
Net Income Margin | 6.7% | -7.97 | -8.54 | 1.77 | 6.35 | 11.67 | 60.62 | 78.09 | 111 | -2.80 | -1.61 | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -19.5% | -41,838,000 | -35,018,000 | -32,631,000 | 174,539,000 | -25,395,000 | -26,436,000 | -15,267,000 | -18,289,000 | -23,764,000 | -27,680,000 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 15.7% | 437 | 378 | 493 | 527 | 560 | 591 | 458 | 346 | 369 | 419 | 123 | 145 | 161 | 181 | 227 | 71.00 | 118 | 137 | 91.00 | 90.00 | 101 |
Current Assets | 28.9% | 281 | 218 | 351 | 389 | 417 | 443 | 289 | 193 | 210 | 248 | 91.00 | 112 | 132 | 151 | 196 | 39.00 | 86.00 | 104 | 64.00 | 66.00 | 77.00 |
Cash Equivalents | -74.2% | 2.00 | 7.00 | 31.00 | 7.00 | 4.00 | 11.00 | 146 | 14.00 | 9.00 | 101 | 7.00 | 13.00 | 9.00 | 11.00 | 21.00 | 2.00 | 7.00 | 3.00 | 9.00 | 4.00 | 4.00 |
Inventory | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net PPE | -7.5% | 2.00 | 2.00 | 2.00 | - | - | 1.00 | - | - | - | - | - | - | - | - | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Current Liabilities | 10.8% | 59.00 | 53.00 | 147 | 144 | 139 | 136 | 40.00 | 39.00 | 35.00 | 52.00 | 43.00 | 48.00 | 43.00 | 37.00 | 48.00 | 38.00 | 58.00 | 55.00 | 47.00 | 41.00 | 45.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.00 |
Shareholder's Equity | -185.5% | -71.33 | -24.98 | - | 21.00 | 55.00 | 86.00 | - | - | - | 24.00 | - | - | - | -120 | - | - | - | - | - | - | - |
Retained Earnings | -4.9% | -790 | -753 | -744 | -706 | -669 | -635 | -764 | -746 | -716 | -683 | -963 | -941 | -912 | -872 | -835 | -796 | -763 | -734 | -705 | -688 | -674 |
Additional Paid-In Capital | -1.3% | 719 | 728 | 730 | 727 | 724 | 721 | 718 | 714 | 711 | 706 | 700 | 694 | 690 | 751 | 747 | 635 | 631 | 625 | 565 | 558 | 553 |
Shares Outstanding | -5.2% | 58.00 | 61.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 62.00 | 62.00 | 62.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 328 | - | - | - | 166 | - | - | - | 887 | - | - | - | 762 | - | - | - | 729 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -19.7% | -41,780 | -34,900 | -32,598 | -32,341 | 174,539 | -25,382 | -26,439 | -19,469 | -15,193 | -18,215 | -23,661 | -27,592 | -40,254 | -18,407 | -34,941 | -37,597 | -9,141 | -23,014 | -7,522 | -16,589 | -12,948 |
Share Based Compensation | -1.2% | 2,658 | 2,691 | 3,235 | 2,771 | 2,953 | 3,264 | 3,844 | 3,072 | 3,892 | 5,548 | 5,694 | 3,117 | 3,271 | 3,803 | 3,824 | 3,822 | 3,476 | 3,317 | 3,496 | 3,598 | 3,374 |
Cashflow From Investing | -153.3% | -61,925 | 116,243 | 57,167 | 35,375 | -181,331 | -108,491 | 32,999 | 24,741 | -76,813 | 112,418 | 17,896 | 30,411 | 32,985 | 7,996 | -118,397 | 32,594 | 10,776 | -39,239 | 9,339 | 15,212 | 11,287 |
Cashflow From Financing | 193.8% | 98,431 | -104,953 | -483 | -260 | -388 | -651 | 124,837 | -99.00 | 161 | -810 | 478 | 855 | 5,796 | -163 | 172,449 | -151 | 2,399 | 56,476 | 3,058 | 1,309 | -146 |
Buy Backs | - | 11,851 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Costs and expenses: | ||
Research and development | $ 26,770 | $ 24,610 |
Selling, general and administrative | 12,264 | 11,103 |
Total costs and expenses | 39,034 | 35,713 |
Loss from operations | (39,034) | (35,713) |
Interest expense | (8,231) | (7,933) |
Interest and other income | 3,415 | 3,963 |
Net loss from continuing operations | (43,850) | (39,683) |
Net income from discontinued operations, net of tax | 6,666 | 5,982 |
Net loss | $ (37,184) | $ (33,701) |
Basic and diluted net income (loss) per share: | ||
Net loss from continuing operations (in dollars per share) | $ (0.75) | $ (0.63) |
Net income from discontinued operations (in dollars per share) | 0.12 | 0.09 |
Net loss (in dollars per share) | $ (0.63) | $ (0.54) |
Weighted-average shares used to compute basic and diluted net income (loss) per share (in shares) | 58,800,716 | 62,828,765 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,831 | $ 7,105 |
Short-term investments | 228,503 | 164,743 |
OMIDRIA contract royalty asset, short-term | 29,519 | 29,373 |
Receivables | 7,642 | 8,096 |
Prepaid expense and other assets | 13,463 | 8,581 |
Total current assets | 280,958 | 217,898 |
OMIDRIA contract royalty asset | 135,909 | 138,736 |
Right of use assets | 17,767 | 18,631 |
Property and equipment, net | 1,804 | 1,950 |
Restricted investments | 1,054 | 1,054 |
Total assets | 437,492 | 378,269 |
Current liabilities: | ||
Accounts payable | 6,182 | 7,712 |
Accrued expenses | 28,402 | 31,868 |
Current portion of OMIDRIA royalty obligation | 19,130 | 8,576 |
Current portion of lease liabilities | 5,342 | 5,160 |
Total current liabilities | 59,056 | 53,316 |
Convertible senior notes, net | 213,463 | 213,155 |
OMIDRIA royalty obligation, non-current | 217,459 | 116,550 |
Lease liabilities, non-current | 16,754 | 18,143 |
Other accrued liabilities, non-current | 2,088 | 2,088 |
Commitments and contingencies (Note 10) | ||
Shareholders’ equity (deficit): | ||
Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at March 31, 2024 and December 31, 2023. | 0 | 0 |
Common stock, par value $0.01 per share, 150,000,000 shares authorized at March 31, 2024 and December 31, 2023; 57,942,695 and 61,128,597 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively. | 579 | 611 |
Additional paid-in capital | 718,807 | 727,936 |
Accumulated deficit | (790,714) | (753,530) |
Total shareholders’ deficit | (71,328) | (24,983) |
Total liabilities and shareholders’ equity (deficit) | $ 437,492 | $ 378,269 |